| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | John Beilby | |
| P2860 | cites work | Identification of the cystic fibrosis gene: chromosome walking and jumping | Q22299423 |
| A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis | Q24310146 | ||
| Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides | Q24315970 | ||
| Identification of four gene variants associated with myocardial infarction | Q24536320 | ||
| Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease | Q24685210 | ||
| Gene variants of VAMP8 and HNRPUL1 are associated with early-onset myocardial infarction | Q28239724 | ||
| Cystic fibrosis | Q28250200 | ||
| Huntington's disease | Q28284355 | ||
| Definition and clinical importance of haplotypes | Q28303291 | ||
| Identification of the cystic fibrosis gene: genetic analysis | Q29614402 | ||
| A population-based study of the clinical expression of the hemochromatosis gene | Q33872904 | ||
| Hereditary hemochromatosis--a new look at an old disease | Q34324340 | ||
| Gene-environment interactions in human diseases | Q34407923 | ||
| Hereditary hemochromatosis: perspectives of public health, medical genetics, and primary care | Q35051943 | ||
| TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis | Q35533799 | ||
| Molecular pathology of the CFTR locus in male infertility | Q36037679 | ||
| Modifier genetics: cystic fibrosis | Q36241654 | ||
| The molecular genetics of haemochromatosis. | Q36244891 | ||
| Genetic epidemiology and public health: hope, hype, and future prospects | Q36293973 | ||
| The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction | Q36462035 | ||
| Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease | Q36678689 | ||
| Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset | Q37073913 | ||
| Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. | Q40562181 | ||
| Molecular genetics of Huntington's disease | Q40769360 | ||
| A functional haplotype in the 5' flanking region of the factor VII gene is associated with an increased risk of coronary heart disease | Q42450936 | ||
| Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction | Q44212606 | ||
| Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis | Q44402404 | ||
| Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation | Q44506851 | ||
| Diagnosis of Huntington disease: model for a predictive testing program based on understanding the stages of psychological response | Q45289322 | ||
| Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension | Q47618605 | ||
| Power tools for human genetics | Q48111196 | ||
| Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens | Q49203017 | ||
| Cystic fibrosis carrier screening in two New South Wales country towns. | Q51035199 | ||
| Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men. | Q51928036 | ||
| How many genes underlie the occurrence of common complex diseases in the population? | Q51968332 | ||
| Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers. | Q53838842 | ||
| Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. | Q55033106 | ||
| The prognostic role of a gene signature from tumorigenic breast-cancer cells. | Q55042952 | ||
| Apolipoprotein AIV Gene Variant S347 Is Associated With Increased Risk of Coronary Heart Disease and Lower Plasma Apolipoprotein AIV Levels | Q61560190 | ||
| Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study | Q61560288 | ||
| International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease | Q72819471 | ||
| Hepatitis C, iron, and hemochromatosis gene mutations. A meaningful relationship or simple cohabitation? | Q73668107 | ||
| ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group | Q74450647 | ||
| Hereditary hemochromatosis | Q80064354 | ||
| Depression and suicidal ideation after predictive testing for Huntington's disease: a two-year follow-up study | Q80246032 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 52-59 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Clinical Biochemist Reviews | Q15766391 |
| P1476 | title | DNA: where to now? | |
| P478 | volume | 28 |
Search more.